NBIX vs VACHU
Neurocrine Biosciences Inc (NBIX) versus Voyager Acquisition Corp Unit (VACHU) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Voyager Acquisition Corp Unit (VACHU) is a shell companies company listed on US.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
VACHU does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the NBIX and VACHU stock pages for the full models.
Not investment advice.